TY  - JOUR
AU  - Garcia-Medina, Jose J
AU  - Benitez-Del-Castillo, Javier
AU  - Rodríguez-Agirretxe, Iñaki
AU  - Lopez-Lopez, Fernando
AU  - Moreno-Valladares, Antonio
AU  - VISIONARY Study Group (Spain)
PY  - 2022
DO  - 10.1089/jop.2021.0099
UR  - http://hdl.handle.net/10668/19702
T2  - Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
AB  - Purpose: Data are presented from ophthalmology clinics in Spain participating in the VISIONARY study, examining the effectiveness, tolerability, and safety of the preservative-free tafluprost (0.0015%) and timolol (0.5%) fixed-dose combination (PF...
LA  - en
KW  - fixed-dose combination
KW  - ocular hypertension
KW  - open-angle glaucoma
KW  - preservative-free topical medication
KW  - tafluprost
KW  - timolol
KW  - Adult
KW  - Aged
KW  - Antihypertensive Agents
KW  - Drug Combinations
KW  - Female
KW  - Glaucoma
KW  - Glaucoma, Open-Angle
KW  - Humans
KW  - Intraocular Pressure
KW  - Male
KW  - Ocular Hypertension
KW  - Preservatives, Pharmaceutical
KW  - Prospective Studies
KW  - Prostaglandins
KW  - Prostaglandins A
KW  - Prostaglandins F
KW  - Prostaglandins, Synthetic
KW  - Spain
KW  - Timolol
TI  - Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain.
TY  - research article
VL  - 38
ER  -